Page 24 - Read Online

Page 4 of 5 Bell et al. Mini-invasive Surg 2022;6:43 https://dx.doi.org/10.20517/2574-1225.2022.30

credentialling best provided by a multidisciplinary society.

Historically, foregut technologies helped create a platform for, and aided in the birth of the AFS and EFS. As
foregut technology innovation continues, these societies will continue to partner with industry in a positive,
ethically coherent fashion. Everything we do, from eating with a fork to sending a human into space,
depends on technology. With an ever-increasing rate of technological innovation, AFS and EFS are
committed to being receptive, researching, and promoting proper use by specialists of innovations that
demonstrate patient benefit.

DECLARATIONS
Authors’ contributions
Contributed equally to the manuscript: Bell R, Woodworth P, Freeman K

Availability of data and materials
Not applicable.

Financial support and sponsorship
None.

Conflicts of interest
Bell R is the consultant of Ethicon Endo-Surgery, Intuitive; Woodworth P is the consultant of Ethicon
Endo-Surgery.

Ethical approval and consent to participate
Not applicable.

Consent for publication
Not applicable.

Copyright
© The Author(s) 2022.

REFERENCES
1. Ganz RA, Gostout CJ, Grudem J, Swanson W, Berg T, DeMeester TR. Use of a magnetic sphincter for the treatment of GERD: a
feasibility study. Gastrointest Endosc 2008;67:287-94. DOI PubMed
2. Smith CD, Ganz RA, Lipham JC, Bell RC, Rattner DW. Lower esophageal sphincter augmentation for gastroesophageal reflux
disease: the safety of a modern implant. J Laparoendosc Adv Surg Tech A 2017;27:586-91. DOI PubMed
3. Rogers BD, Valdovinos LR, Crowell MD, Bell R, Vela MF, Gyawali CP. Number of reflux episodes on pH-impedance monitoring
associates with improved symptom outcome and treatment satisfaction in gastro-oesophageal reflux disease (GERD) patients with
regurgitation. Gut 2021;70:450-5. DOI PubMed
4. Bell R, Lipham J, Louie BE, et al. Magnetic sphincter augmentation superior to proton pump inhibitors for regurgitation in a 1-year
randomized trial. Clin Gastroenterol Hepatol 2020;18:1736-1743.e2. DOI PubMed
5. Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG clinical guideline for the diagnosis and
management of gastroesophageal reflux disease. Am J Gastroenterol 2022;117:27-56. DOI PubMed PMC
6. Yadlapati R, Gyawali CP, Pandolfino JE; CGIT GERD Consensus Conference Participants. AGA clinical practice update on the
personalized approach to the evaluation and management of GERD: expert review. Clin Gastroenterol Hepatol 2022;20:984-994.e1.
DOI PubMed
7. Rajan A, Van Sante N, Gawlicka AK, et al. Transoral incisionless fundoplication using EsophyX for the treatment of GERD: two-year
r e s u l t s o f a f e a s i b i l i t y s t u d y . A v a i l a b l e f r o m :
https://journals.lww.com/jcge/Citation/2008/04001/Abstracts_for_the_9th_World_Congress_of_OESO.1.aspx [Last accessed on 8 Jun
2022].